PsyBio Therapeutics Corp

OTCPK:PSYBF (USA)   Ordinary Shares
$ 0.01 -0.0019 (-24.05%) 09:55 AM EST
At Loss
Market Cap:
$ 766.00K
Enterprise V:
$ 849.00K
Volume:
2.13K
Avg Vol (2M):
35.48K
Also Trade In:
Volume:
2.13K
At Loss
Avg Vol (2M):
35.48K

Business Description

PsyBio Therapeutics Corp
NAICS : 541714 SIC : 3741
ISIN : CA6936971044

Share Class Description:

PSYBF: Ordinary Shares
Description
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset -5.97
Debt-to-Equity -0.06
Debt-to-EBITDA -0.04
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 58.64
9-Day RSI 54.44
14-Day RSI 52.84
6-1 Month Momentum % 6.58
12-1 Month Momentum % -76.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.05
Quick Ratio 0.05
Cash Ratio 0.01
Days Payable 7513.63

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -46.91

Profitability Rank

Name Current Vs Industry Vs History
ROA % -529.33
ROIC % -857.24
ROC (Joel Greenblatt) % -2151.74

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.3
EV-to-EBITDA -0.31
EV-to-FCF -1.15
Earnings Yield (Greenblatt) % -333.33
FCF Yield % -116.06

Financials

PSYBF's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:PSYBF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

PsyBio Therapeutics Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.03
Beta 0
Volatility % 104.59
14-Day RSI 52.84
14-Day ATR ($) 0.002247
20-Day SMA ($) 0.006522
12-1 Month Momentum % -76.06
52-Week Range ($) 0.003 - 0.0521
Shares Outstanding (Mil) 127.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PsyBio Therapeutics Corp Filings

Filing Date Document Date Form
No Filing Data

PsyBio Therapeutics Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

PsyBio Therapeutics Corp Frequently Asked Questions

What is PsyBio Therapeutics Corp(PSYBF)'s stock price today?
The current price of PSYBF is $0.01. The 52 week high of PSYBF is $0.05 and 52 week low is $0.00.
When is next earnings date of PsyBio Therapeutics Corp(PSYBF)?
The next earnings date of PsyBio Therapeutics Corp(PSYBF) is .
Does PsyBio Therapeutics Corp(PSYBF) pay dividends? If so, how much?
PsyBio Therapeutics Corp(PSYBF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1